|
|
SFX by Ex Libris Inc.
|
List of services to meet your request
|
||||||||
|
||||||||
© 2024 SFX by Ex Libris Inc. | Cookie Policy
CrossRef Omogočeno
![](https://beacon01.alma.exlibrisgroup.com/boom/apache_pb.gif?SRVR=adz.izum.si&IP=193.2.126.232&A=SFX&P=SFXMenu&S=s4184DAD2-5B40-11EF-A751-374785CE164B&I=39IZM&T=&OP=Display&O=html&O1=15241430&O2=4340000000113444&O3=&O4=summon.serialssolutions.com&O5=https%3A%2F%2Fadz.izum.si%2Fsfxlcl41%3Fctx_enc%3Dinfo%253Aofi%252Fenc%253AUTF-8%26ctx_ver%3DZ39.88-2004%26rfr_id%3Dinfo%253Asid%252Fsummon.serialssolutions.com%26rft.atitle%3DThe%2520level%2520of%2520anti-%2528GalNAc%2520beta%2529%2520and%2520anti-para-Forssman%2520disaccharide%2520IgG%2520antibodies%2520in%2520patients%2520with%2520gastrointestinal%2520cancer%253A%2520relation%2520to%2520survival%26rft.au%3DKurtenkov%252C%2520O%2520A%26rft.au%3DSergeyev%252C%2520B%2520L%26rft.au%3DSmorodin%252C%2520E%2520P%26rft.date%3D2013-06-01%26rft.externalDocID%3D23828381%26rft.genre%3Darticle%26rft.issn%3D1812-9269%26rft.issue%3D2%26rft.jtitle%3DExperimental%2520oncology%26rft.spage%3D89%26rft.volume%3D35%26rft_id%3Dinfo%253Apmid%252F23828381%26rft_val_fmt%3Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal&O6=1-MESSAGE_NO_FULLTXT_LCL-getMessageNoFullTxt-object,2-COBIB_SI_LCL-getHolding-object,3-REFWORKS_EXPORT_TOOL-getReference-object,4-NCBI_PUBMED_FREE-getCitedRecord-object,5-GOOGLE_SCHOLAR_FREE-getWebSearch-object,6-WWW_SEARCH_ENGINES_FREE-getWebSearch-object&O7=1.010165&O8=N&O9=<ctx:context-object identifier="urn:sfxstat:15241430-s4184DAD2-5B40-11EF-A751-374785CE164B" timestamp="2024-08-15T21:55:01Z" xmlns:ctx="info:ofi/fmt:xml:xsd:ctx">
<ctx:referent>
<ctx:identifier>urn:sfxid:4340000000113444</ctx:identifier>
<ctx:metadata-by-val>
<ctx:format>info:ofi/fmt:xml:xsd:journal</ctx:format>
<ctx:metadata>
<jnl:journal xmlns:jnl="info:ofi/fmt:xml:xsd:journal">
<jnl:atitle>The level of anti-(GalNAc beta) and anti-para-Forssman disaccharide IgG antibodies in patients with gastrointestinal cancer: relation to survival.</jnl:atitle>
<jnl:jtitle>Experimental oncology (Online)</jnl:jtitle>
<jnl:date>2013-06-00</jnl:date>
<jnl:spage>89</jnl:spage>
<jnl:epage>92</jnl:epage>
<jnl:issn>2312-8852</jnl:issn>
<jnl:volume>35</jnl:volume>
<jnl:issue>2</jnl:issue>
<jnl:genre>article</jnl:genre>
<jnl:eissn>2312-8852</jnl:eissn>
<jnl:language>eng</jnl:language>
<jnl:authors></jnl:authors>
</jnl:journal>
</ctx:metadata>
</ctx:metadata-by-val>
</ctx:referent>
<ctx:requester>
<ctx:identifier>urn:ip:fec3524e399c42ce96fe0de0fbbe0ac277071af9</ctx:identifier>
<ctx:identifier>urn:UUID:s4184DAD2-5B40-11EF-A751-374785CE164B</ctx:identifier>
</ctx:requester>
<ctx:referrer>
<ctx:identifier>info:sid/summon.serialssolutions.com</ctx:identifier>
</ctx:referrer>
<ctx:service-type>
<ctx:metadata-by-val>
<ctx:format>info:ofi/fmt:xml:xsd:svcList</ctx:format>
<ctx:metadata>
<svc:svcList xmlns:svc="http://www.exlibrisgroup.com/schema/info:ofi/fmt:xml:xsd:sch_svc"></svc:svcList>
</ctx:metadata>
</ctx:metadata-by-val>
</ctx:service-type>
<ctx:resolver>
<ctx:identifier>https://adz.izum.si/sfxlcl41</ctx:identifier>
</ctx:resolver>
</ctx:context-object>
&)